Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kannan Thanukrishnan"'
Autor:
Saiful F. Haq, Anirudh P. Shanbhag, Subbulakshmi Karthikeyan, Imran Hassan, Kannan Thanukrishnan, Abhishek Ashok, Sunilkumar Sukumaran, S. Ramaswamy, Nagakumar Bharatham, Santanu Datta, Shalaka Samant, Nainesh Katagihallimath
Publikováno v:
Microbial Cell Factories, Vol 17, Iss 1, Pp 1-14 (2018)
Abstract Introduction Chemical industries are constantly in search of an expeditious and environmentally benign method for producing chiral synthons. Ketoreductases have been used as catalysts for enantioselective conversion of desired prochiral keto
Externí odkaz:
https://doaj.org/article/43ab58b82aa44791bd63ed1384dcab10
Autor:
Imran Hassan, Shalaka Samant, Saiful F. Haq, Sunilkumar Sukumaran, Nainesh Katagihallimath, Subbulakshmi Karthikeyan, Anirudh P. Shanbhag, Nagakumar Bharatham, Santanu Datta, Abhishek Ashok, S. Ramaswamy, Kannan Thanukrishnan
Publikováno v:
Microbial Cell Factories, Vol 17, Iss 1, Pp 1-14 (2018)
Microbial Cell Factories
Microbial Cell Factories
Introduction Chemical industries are constantly in search of an expeditious and environmentally benign method for producing chiral synthons. Ketoreductases have been used as catalysts for enantioselective conversion of desired prochiral ketones to th
Autor:
Chrysina, Evangelia D., Kosmopoulou, Magda N., Kardakaris, Rozina, Bischler, Nicolas, Leonidas, Demetres D., Kannan, Thanukrishnan, Loganathan, Duraikkannu, Oikonomakos, Nikos G. *
Publikováno v:
In Bioorganic & Medicinal Chemistry 2005 13(3):765-772
Publikováno v:
Journal of Heterocyclic Chemistry. 54:1949-1956
Tumor angiogenesis has become an important target for antitumor therapy, with most current therapies aimed at blocking the vascular endothelial growth factor (VEGF) pathway. The VEGF and its receptors have been implicated as key factors in tumor angi
Publikováno v:
Journal of Heterocyclic Chemistry. 54:1723-1728
The sprouting of new blood vessels, or angiogenesis, is necessary for any solid tumor to grow large enough to cause life-threatening disease. Vascular endothelial growth factor (VEGF) is one of the key promoters of tumor-induced angiogenesis. Inhibit
Publikováno v:
Journal of Heterocyclic Chemistry. 54:1065-1070
The identification of agents with antiproliferative activity against endothelial cells has significant value for the treatment of many angiogenesis-dependent pathologies. The vascular endothelial growth factor (VEGF) and its receptors have been impli
Publikováno v:
Asian Journal of Chemistry. 28:2122-2130
Autor:
Saiful Haq, Anirudh Shanbhag, Subbulakshmi Karthikeyan, Hassan, Imran, Kannan Thanukrishnan, Abhishek Ashok, Sunilkumar Sukumaran, S. Ramaswamy, Nagakumar Bharatham, Santanu Datta, Shalaka Samant, Nainesh Katagihallimath
Additional file 1. Supplementary Information.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0434b2c04a4f3ac9bbd7d7c43ce05a9
Autor:
Kannan, Thanukrishnan1, Loganathan, Duraikkannu1 loganath@iitm.ac.in, Bhatia, Yukti2, Mishra, Saroj2, Bisaria, Virendra S.2
Publikováno v:
Biocatalysis & Biotransformation. Jan/Feb2004, Vol. 22 Issue 1, p1-7. 7p.
Publikováno v:
In Bioorganic & Medicinal Chemistry Letters 2001 11(18):2433-2435